|
Recent discoveries in genomics and proteomics, as well as continued
advances in imaging technology, are revolutionising the world of molecular
medicine, and taking us into a new era of personalised medicine. Internationally
renowned scientists from three continents visualise how this might occur.
We then explain how our businesses are positioned to drive innovation
in global markets and so remain at the forefront of these exciting changes.
April 2001
 
|
Jim Watson argues that banishing
genetic disability in all its manifold forms
must be the primary concern. |
George Poste believes medical science is on the way to tailor-made
treatment of patients. |
Mathias Uhlén explains why it is a
much more difficult task to understand
the human genome than to map it. |
Yusuke Nakamura shows us just how
powerful a tool genetic polymorphism
- SNPs - promises to be for doctors. |
Graham Casey and George Stark
address the particular multi-gene
problems of prostate cancers. |
Susan Greenfield introduces us to the complexities of brain behaviour
and disorder. |
Imaging technology will continue to be
driven by the need for better disease
management, and by a broadening
spectrum of clinical uses. |
Increasingly ingenious analytical
tools and their reagents are fuelling
a burgeoning international market
in life sciences R&D. |
 Download
Visionaries as a PDF document [4.3Mb]
|
